Mycobacterial ATP synthase as drug target  by Haagsma, Anna C. et al.
physiology as they control ionic conditions in the cell and energise
osmotic potentials, secondary transport schemes and ionotropic
signalling. A surprising finding from the Na+,K+-ATPase structure
was the docking of two conserved tyrosine residues at the C-terminus
of the alpha subunit into the transmembrane domain, hinting that this
was a previously unidentified regulatory element. Several mutations
causing human neurological syndromes have subsequently been
mapped to the C-terminal structure element, also clearly indicating
that conservation of the structure is important for pump function.
Mutational analysis confirmed this and prompted our further analysis
by electrophysiology andmolecular dynamics simulations, which have
shown a profound effect of the C-terminus on the electrogenic
transport properties. We further propose that the C-terminal region
forms a binding pocket that can be exploited for pharmacological
intervention in cardiovascular and neurological disease.
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In deenergized mitochondria, a small regulatory peptide called IF1
(bIF1 in bovine, yIF1 in yeast) binds to ATP synthase and blocks ATP
hydrolysis. In crystallized bovine F1-ATPase in complexwith IF1, residues
22–49 of bIF1 are locked at anαβ catalytic interface,while residues 8–18
mainly interactwithγ [1]. Itwas shown that deletion of residues 1–13 of
bIF1 did not affect its affinity for the enzyme [2], while deletion of
residues 1–17 [2] or 1–21 [3] seriously decreased it. We have examined
the consequences of length changes in theN-terminuspart of yIF1 on the
kinetics of inhibition of isolated F1-ATPase. Determination of the rate
constant of IF1 binding to F1 (kon) [4] and of its rate constant of
dissociation from the complex (koff) allowed to discriminate effects of
yIF1 modifications on binding site recognition and on the inhibited
complex stability. Deletion of yIF1 residues 1–13 (corresponding to bIF1
residues 1–18) changed neither kon, nor koff. Deletion of residues 1–14
did not change kon and slightly increased koff. Deletion of residues 1–15
increased kon by a factor 2 and koff at least by a factor 20.Wepropose that
residues 1–15 of yIF1 do not play any role in molecular recognition and
might even hamper it. On the other hand, residues 14–15 (but not
residues 1–13) participate in the stabilization of F1–IF1 complex. Quite
surprisingly, considerable lengthening of theN-terminus domain (by 44
residues) did not affect kon despite the expected increase of steric
hindrance. It increased koff more than 10 fold. We conclude that IF1
probably approaches the catalytic interface with its N-terminus tail
folded back. Once IF1 is bound by its medium domain to α and β
subunits, theN-terminus spreads around theγ subunit.Weare currently
checkingmore in depth thismodel by attaching a small globular protein
to theN-terminus domain of yIF1. Our results also suggest thatγ subunit,
that interacts with the N-terminus part of IF1, plays a minor role in the
inhibition mechanism.
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Recently, ATP synthase has come into focus as a novel antibiotic
target. Previously we showed that diarylquinolines, a new class of
anti-tuberculosis compounds presently in phase III clinical tests,
efficiently kill Mycobacterium tuberculosis by inhibiting ATP synthase
[1, 2]. Diarylquinolines are highly selective, we found that the lead
compound of this drug class inhibits mycobacterial ATP synthesis at
nanomolar concentrations (IC50<10 nM), but has only a minimal
effect on ATP synthesis in human mitochondria (IC50>200 μM) [3].
These results demonstrate that proteins of energy metabolism,
although conserved among prokaryotes and eukaryotes, can never-
theless be used as efficient antibiotic targets. The molecular basis for
the observed selectivity is presently under investigation in our
laboratory. The affinity of ATP synthase for diarylquinolines decreased
significantly in the presence of high salt concentrations, indicating
that electrostatic interactions play an important role in binding of this
inhibitor. However, competition experiments showed that diarylqui-
nolines do not directly compete with protons for the same binding
site. Pinpointing the binding niche of this drug is under way in and
recent progress will be reported. As affinity of several ATP synthase
inhibitors depends on this enzyme's mode of action (ATP synthesis/
high PMF versus ATP hydrolysis/low PMF mode) we investigated the
function of ATP synthase in two mycobacterial strains. Whereas
inverted membrane vesicles were clearly active in ATP synthesis, they
were unable to set-up a proton motive force with ATP. These results
show that mycobacterial ATP synthase is strongly blocked in ATP
hydrolysis mode. The physiological function of this enzyme appears
to be synthesis of ATP, not maintenance of the proton motive force.
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More than 20 high resolution structures of mitochondrial F1-
ATPase have been obtained since the first structure was described in
1994 [1]. These structures have provided the basis for the description
of the conformations of the three catalytic β-subunits in the ground
state [2] and in a transition state intermediate during the catalytic cycle
[3]. We have compared the crystal structures of F1-ATPases from
bovine and yeast mitochondria, obtained with crystals with various
space groups and unit cell sizes. We have examined the way that F1-
complexes are packed in the crystal lattices to determine whether the
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